Marie Stopes International
13
0
0
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
7.7%
1 terminated/withdrawn out of 13 trials
90.0%
+3.5% vs industry average
8%
1 trials in Phase 3/4
11%
1 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
A Study on the Feasibility and Acceptability of Pericoital Levonorgestrel 1.5mg
Role: collaborator
Evaluation of Values Clarification and Attitude Transformation Workshops on Abortion and Family Planning Service Provision and Client Experience
Role: collaborator
Using mHealth to Promote Post-Menstrual Regulation Contraceptive Uptake and Continuation in Bangladesh
Role: lead
Mobile Technology for Improved Family Planning
Role: lead
Improving Person Centered Care for Post Abortion Patients in Kenya
Role: collaborator
Right to Health and Freedom From Violence
Role: collaborator
Evaluating an Intervention to Increase Use of Call Centre Support for Self-managed Medical Abortion
Role: lead
Behavioural Insights to Improve Take up of SRH Services (Uganda)
Role: lead
PAFP Provider Feedback Trial in Nepal
Role: lead
A Study Comparing Implant Provision by Community Health Extension Workers With Nurses and Midwives in Nigeria
Role: lead
Medical Abortion at Gestational Age of 8 to ≤9 Weeks Versus >9 to ≤12 Weeks
Role: collaborator
Kenya Sino-implant (II) PK Study
Role: collaborator
A Prospective Observational Study of the Clinical Performance of Zarin in Madagascar
Role: collaborator
All 13 trials loaded